| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.926 | 17.405 | 39.871 | 149.700 | 300.629 |
| Total Income - EUR | - | - | - | - | - | 1.927 | 17.920 | 40.194 | 149.910 | 300.705 |
| Total Expenses - EUR | - | - | - | - | - | 6.155 | 30.844 | 64.974 | 191.569 | 322.033 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -4.228 | -12.924 | -24.779 | -41.659 | -21.328 |
| Net Profit/Loss - EUR | - | - | - | - | - | -4.281 | -13.446 | -25.286 | -41.659 | -21.328 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Geneceutica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 70.892 | 63.511 | 49.359 | 56.997 |
| Current Assets | - | - | - | - | - | 32.940 | 29.086 | 37.266 | 88.664 | 109.336 |
| Inventories | - | - | - | - | - | 11.125 | 21.229 | 24.353 | 66.632 | 67.788 |
| Receivables | - | - | - | - | - | 11.888 | 827 | 9.326 | 20.762 | 23.187 |
| Cash | - | - | - | - | - | 9.926 | 7.029 | 3.587 | 1.271 | 18.361 |
| Shareholders Funds | - | - | - | - | - | -4.074 | -17.430 | -42.770 | -84.299 | -105.156 |
| Social Capital | - | - | - | - | - | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | 37.014 | 117.408 | 143.547 | 222.583 | 272.042 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 119 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Geneceutica S.r.l.